SPS
BCAB icon

Susquehanna Portfolio Strategies’s BioAtla BCAB Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-374
Closed -$46K – 803
2023
Q4 		$46K Buy
+374
New +$32.4K ﹤0.01% 989

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna Portfolio Strategies's BCAB Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of BioAtla (BCAB) in Q1 2024, closing a stake of 374 shares — an estimated $46K sold.

Susquehanna Portfolio Strategies first reported a position in BCAB in Q4 2023 and held it in 1 quarter. The position peaked at $46K in Q4 2023. 82 funds tracked by Wall St. Rank hold BCAB as of Q1 2024.

  • Susquehanna Portfolio Strategies reported no remaining BioAtla position as of Q1 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 374 BioAtla shares in Q1 2024, an estimated $46K.
  • Susquehanna Portfolio Strategies first reported a position in BioAtla in Q4 2023 and held it in 1 quarter.
  • Susquehanna Portfolio Strategies's BioAtla position peaked at $46K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held BioAtla as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.